Finding relief in the aftermath of Hurricane Maria: A patient’s journey from Puerto Rico to the National Institutes of Health

Jesus Garces-Soto and his wife, Lyssette Santiago, never expected to travel from Puerto Rico to the National Institutes of Health (NIH) in Bethesda, Maryland. On the same day that Hurricane Maria, a storm with 150-mile-per-hour winds, made direct landfall on Puerto Rico in 2017, Garces-Soto needed to seek treatment for an infection related to bladder cancer. Destruction from the hurricane took out the hospital’s electricity, and with no generator, it was difficult to provide adequate care. With help from members of the American Cancer Society and the National Cancer Institute, Garces-Soto and Santiago were flown to NIH where Garces-Soto is receiving care from Andrea Apolo, M.D., Investigator and Lasker Clinical Research Scholar in the Genitourinary Malignancies Branch. Read more...

Watching the action unfold: New cryo-EM images capture CRISPR’s interaction with target DNA

Posted: Oct 5, 2017

Using the Nobel-prize winning technique of cryo-EM, researchers led by CCR Senior Investigator Sriram Subramaniam, Ph.D., have captured a series of highly detailed images of a protein complex belonging to the CRISPR system that can be used by bacteria to recognize and destroy foreign DNA. The images reveal the molecule’s form before and after its interaction with DNA and help illuminate both how the complex functions and how it can be blocked. Read more... 

Watching the action unfold: New cryo-EM images capture CRISPR’s interaction with target DNA
Defne Bayik Watson, Ph.D.

CCR Celebrates National Postdoc Appreciation Week 2017

Posted: Oct 3, 2017

National Postdoc Appreciation Week took place Sept. 18-22, 2017, and the Center for Cancer Research (CCR) joined in to celebrate the work of our postdocs. The CCR offers basic and translational research opportunities for pre- and postdoctoral fellows with competitive stipends through the Cancer Research Training Award. Throughout the week, our postdocs shared their reasons for choosing CCR, and we highlighted some of our outstanding postdocs and why CCR is a premier training institution. To get a glimpse into why these postdocs chose CCR for their training, check out this Storify...

CCR Celebrates National Postdoc Appreciation Week 2017

Efsun Arda appointed as NIH Stadtman Investigator

Posted: Oct 2, 2017

H. Efsun Arda, Ph.D., has joined the Laboratory of Receptor Biology and Gene Expression (LRBGE) as a Stadtman tenure track investigator. Dr. Arda spearheaded the development of genomic and epigenetic analysis of primary pancreatic cells obtained from children and adult donors using single cell analysis.  Her research focuses on understanding the genomic information that governs development, differentiation and function of pancreatic cell lineages.  Learn more...
 

Efsun Arda appointed as NIH Stadtman Investigator

October is Breast Cancer Awareness Month

Posted: Oct 2, 2017

To recognize Breast Cancer Awareness Month this October, we are highlighting our researchers who are making discoveries in this field. Read more…

October is Breast Cancer Awareness Month

Recap: Lymphoma Twitter Chat for Blood Cancer Awareness and Childhood Cancer Awareness Month

Posted: Sep 27, 2017

On September 20, 2017, the National Cancer Institute co-hosted a Twitter chat with the Lymphoma Research Foundation for Blood Cancer Awareness and Childhood Cancer Awareness Month. Nirali Shah, M.D., of the Center for Cancer Research, and Nita Seibel, M.D., of the Division of Cancer Treatment and Diagnosis, offered their expertise to discuss lymphoma treatment and trials for children and young adults. This Storify recaps the Twitter chat.

Recap: Lymphoma Twitter Chat for Blood Cancer Awareness and Childhood Cancer Awareness Month

Douglas Lowy and Nirali Shah discuss advancements in cancer treatment at the second annual Chasing Cancer Summit

Posted: Sep 26, 2017

On Monday, September 18, 2017, the second annual Chasing Cancer Summit was held at the Washington Post headquarters in downtown Washington, D.C. The live event brought together a group of experts, including CCR’s Douglas Lowy, M.D., and Nirali Shah, M.D., for discussions on the latest developments in cancer detection and treatment.  Read more...

Douglas Lowy and Nirali Shah discuss advancements in cancer treatment at the second annual Chasing Cancer Summit

Nicholas Restifo awarded 2018 ASM Award in Clinical and Diagnostic Immunology

Posted: Sep 25, 2017

The American Society for Microbiology (ASM) has selected Nicholas Restifo, M.D., Senior Investigator in the Surgery Branch, to receive the 2018 ASM Award in Clinical and Diagnostic Immunology. The award recognizes scientists for their outstanding contributions to microbiology in service of science and the public. Learn more…

Nicholas Restifo awarded 2018 ASM Award in Clinical and Diagnostic Immunology

Combination therapy clinical trial now recruiting patients with metastatic colorectal cancer

Posted: Sep 20, 2017

A new clinical trial tests an approach that may boost the immune system’s ability to attack tumor cells for colorectal cancer that has not responded to other therapies. Read more...

Combination therapy clinical trial now recruiting patients with metastatic colorectal cancer

Clinical trial looks at new methods of assessing treatment response for esophageal cancer

Posted: Sep 12, 2017

Currently, there is no way to accurately evaluate patients' response to treatment or to detect residual esophageal cancer without removing the esophagus. R. Taylor Ripley, M.D., of the Thoracic and Gastrointestinal Oncology Branch is leading a study to determine whether metabolomic signatures or BH3 profiling in biopsy tissues can identify patients who will likely respond well to pre-surgical treatment.  Learn more...

Clinical trial looks at new methods of assessing treatment response for esophageal cancer

CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award

Posted: Sep 6, 2017

Douglas Lowy, M.D., and John Schiller, Ph.D., of CCR’s Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes.

CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award

Pages